Brain Training for Schizophrenia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help people with schizophrenia improve their thinking and daily functioning. It compares two brain training programs: one focuses on early hearing skills, and the other targets overall thinking skills. The trial includes individuals with schizophrenia or schizoaffective disorder who are stable on their current medication and speak English. Participants will be grouped based on hearing test results and will try one of the two programs, called Brain Basics or Brain Training. The goal is to determine if these programs can improve memory and everyday skills. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance cognitive therapies for schizophrenia.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be psychiatrically stable, meaning no changes in your psychotropic medication in the last 21 days.
What prior data suggests that this cognitive remediation approach is safe for individuals with schizophrenia?
In a previous study, cognitive training proved to be safe and well-tolerated by people with schizophrenia. Research shows that programs like Brain Basics and Brain Training can enhance thinking skills without causing major side effects.
Cognitive training, used in both Brain Basics and Brain Training, has undergone testing in many studies. A review of 11 studies with 615 participants with early schizophrenia found this training to be generally safe, with no reports of serious side effects.
Game-based digital programs, like Brain Training, also appear safe. Studies suggest they are not only effective but also safe for people with schizophrenia.
Overall, these treatments aim to improve thinking skills, and existing research supports their safety in humans.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for schizophrenia because they offer a fresh approach to cognitive remediation. Brain Basics is unique as it focuses specifically on early auditory processing, which could enhance cognitive functions by targeting the brain's initial responses to sound. On the other hand, Brain Training covers a broader range of cognitive abilities, aiming to improve overall cognitive performance. These methods stand out since traditional treatments for schizophrenia, like antipsychotic medications, mainly address symptoms rather than improving cognitive deficits. By enhancing cognitive skills, these interventions could provide a significant boost to daily functioning and quality of life for individuals with schizophrenia.
What evidence suggests that this trial's treatments could be effective for schizophrenia?
Research has shown that cognitive remediation (CR) helps people with schizophrenia improve skills such as attention, memory, and learning. Studies indicate that patients participating in CR experience significant improvements in these areas compared to those receiving standard treatment. In this trial, participants will be assigned to one of two cognitive remediation interventions. The Brain Basics method, targeting early sound processing, aims to enhance these benefits further. Meanwhile, the Brain Training method has boosted thinking skills and everyday functioning. Both approaches seek to improve cognitive abilities and daily task management, offering promising options for better outcomes in schizophrenia.23678
Who Is on the Research Team?
Alice Medalia, Ph.D.
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals with a primary diagnosis of schizophrenia or schizoaffective disorder who are psychiatrically stable. They should not have had changes in medication or hospitalization in the last 21 days, and no cognitive remediation in the past 24 months, substance dependence within six months, auditory disorders, significant visual impairment, neurological conditions affecting cognition, or an IQ below 70.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo baseline assessments including early auditory processing, cognitive ability, and functioning
Treatment
Cognitive Remediation (CR) sessions conducted twice a week for 15 weeks
Post-Treatment Assessment
Participants repeat behavioral assessments and EEG paradigms to explore mechanisms of change
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Brain Basics
- Brain Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator